Why Drug Development Depends on Patent Protection
From IPWatchdog Unleashed by Gene Quinn
May 4, 2026 · 58 min · Season 3 · Episode 17
About this episode
Gene Quinn speaks with Brent Bellows about the importance of patent protection in drug development.
Send us Fan Mail This week on IPWatchdog Unleashed, our host and the founder of IPWatchdog, Gene Quinn, speaks with Brent Bellows, a partner with Knowles Intellectual Property Strategies (KIPS) in Atlanta, Georgia, who has a Ph.D. from the University of Alabama at Birmingham in human genetics. Brent traces his path from graduate research in medical genetics and tumor-associated antigens to patent law, including his time at King & Spalding, a clerkship in the Northern District of Georgia, ...
People in this episode
Host: Gene Quinn
Guest: Brent Bellows
Topics covered
- drug development
- patent protection
- intellectual property
- medical genetics
- law
Keywords
- drug development
- patent law
- intellectual property
- medical genetics
- tumor-associated antigens
Mentioned in this episode
Organizations: Knowles Intellectual Property Strategies, King & Spalding
Places: Atlanta, Georgia, University of Alabama at Birmingham
More episodes of IPWatchdog Unleashed
- Is America’s Patent System Ready for the AI Arms Race? · June 8, 2026 · 40 min
- When Antitrust Gets Patents Wrong: Weak Patent Rights Reward Copycats · June 1, 2026 · 48 min
- AI and the Future of Patent Law Firms: Opportunity or Race to the Bottom? · May 25, 2026 · 1h 0m
- Patents, Property Rights, and What Patent Policy Keeps Getting Wrong · May 18, 2026 · 48 min
- Patent Boutiques vs. Big Law: How In-House Teams Allocate Prosecution Work · May 11, 2026 · 52 min
- Proactive IP Risk Management: A Patent Litigator’s Perspective · April 27, 2026 · 48 min
Explore listener stats, chart rankings, contacts and more on the IPWatchdog Unleashed podcast page.